Institutional 13F Filings
Quarterly position changes from hedge funds and institutional investors.
Institutional 13F Filings
Vaughan Nelson Boosts Stake in Artisan Partners Asset Management
Vaughan Nelson Investment Management increased its position in Artisan Partners by 12.6% in the latest quarter.
Institutional 13F Filings
Vaughan Nelson Increases Stake in GATX Corporation
Vaughan Nelson Investment Management added 111,935 shares of GATX, raising its stake by 23% to 597,545 shares.
Institutional 13F Filings
Vaughan Nelson Increases Stake in FirstCash Holdings
Vaughan Nelson Investment Management raised its position in FirstCash Holdings by 9.3% during the latest quarter.
Institutional 13F Filings
Vaughan Nelson Investment Management Takes New Position in Sensient Technologies
Vaughan Nelson Investment Management has initiated a new position in Sensient Technologies, acquiring 901,840 shares.
Institutional 13F Filings
Vaughan Nelson Trims Stake in Sandisk Corporation
Vaughan Nelson reduced its stake in Sandisk by 15%, holding 57,255 shares.
Institutional 13F Filings
Vaughan Nelson Trims Cushman & Wakefield Stake by 2%
Vaughan Nelson Investment Management reduced its stake in Cushman & Wakefield by 181,668 shares in its latest 13F filing.
Institutional 13F Filings
Vaughan Nelson Increases Stake in Valmont Industries
Vaughan Nelson Investment Management raised its Valmont Industries holdings by 9,130 shares.
Institutional 13F Filings
Vaughan Nelson Increases Stake in WESCO International
Vaughan Nelson boosts its WESCO International stake by 31,210 shares, now holding 404,730 shares.
Institutional 13F Filings
Vaughan Nelson Trims Stake in United Rentals
The firm reduced its holding in United Rentals by 32.7% in its latest 13F filing.
Institutional 13F Filings
Vaughan Nelson Increases Sanmina Holdings Significantly
Vaughan Nelson Investment Management raised its stake in Sanmina by 57.5%, reflecting confidence in the company's prospects.
Institutional 13F Filings
Vaughan Nelson Ups Lincoln Electric Holdings Stake by 72%
Vaughan Nelson Investment Management significantly increased its position in Lincoln Electric Holdings, Inc.
Institutional 13F Filings
RTW Investments Acquires New Stake in Ocugen, Inc. (OCGN)
RTW Investments has entered a new position in Ocugen, Inc., acquiring 6.67 million shares.
Institutional 13F Filings
RTW Investments Boosts Stake in Compass Therapeutics
RTW Investments significantly increases its stake in Compass Therapeutics, reflecting a strong vote of confidence.
Institutional 13F Filings
RTW Investments Reduces Stake in Jade Biosciences
RTW Investments cut its position in Jade Biosciences by 60%, now holding 573,205 shares.
Institutional 13F Filings
RTW Investments Takes New Position in Dianthus Therapeutics
RTW Investments acquires 248,063 shares of Dianthus Therapeutics, valued at $20.36 million.
Institutional 13F Filings
RTW Investments Increases Stake in Fulgent Genetics
RTW Investments significantly boosted its stake in Fulgent Genetics, adding over half a million shares.
Institutional 13F Filings
RTW Investments Reduces Beta Bionics Stake by 20%
RTW Investments trimmed its holdings in Beta Bionics by 500,000 shares, a 20% decrease.
Institutional 13F Filings
RTW Investments Ups Stake in Evommune, Inc.
RTW Investments increased its Evommune holdings by 17%, adding 218,564 shares.
Institutional 13F Filings
RTW Investments Takes New Position in Waystar Holding Corp.
RTW Investments acquired 1.63 million shares of Waystar Holding Corp., marking a new stake in the company.
Institutional 13F Filings
RTW Investments Increases Stake in Aquestive Therapeutics
RTW Investments boosted its position in Aquestive Therapeutics by 18.8%, now holding 7.43 million shares.
Institutional 13F Filings
RTW Investments Opens New Stake in Aktis Oncology
RTW Investments has bought 1.59 million shares of Aktis Oncology, valued at $34.9 million.
Institutional 13F Filings
RTW Investments Acquires New Stake in Candel Therapeutics
RTW Investments has taken a new stake in Candel Therapeutics, acquiring over 6.4 million shares.
Institutional 13F Filings
RTW Investments Increases Castle Biosciences Holdings by 30%
RTW Investments added 643,098 shares in Castle Biosciences, now holding 2.76 million shares.
Institutional 13F Filings
RTW Investments Increases Position in Replimune Group
RTW Investments adds 216,564 shares in Replimune Group, showing confidence in the biotech firm.